The committee is underpinned by Translational Platforms to develop Tomorrow’s Healthcare as articulated in the MACH Strategy 2020 to 2025 which include:

  • Clinical Research Support Hub
  • Data-Driven Healthcare Platform
  • Clinical Research Imaging Platform
  • Medical Devices and Implantables Platform
  • Melbourne Therapeutics Development Leadership Group
  • Precision Medicine Platform
  • Human Immunology, Immunotherapy and Vaccines Platform
  • Researcher Clinical Accreditation Platform

Note: This is not an exhaustive list and further Translational Platforms may be established based on need and opportunity.


Professor Kathryn North AC

Murdoch Children’s Research Institute


Nick Walsh

Nick Walsh

Responsibilities include:

  • ​Identifying strategic opportunities to develop translational research across MACH
  • Overseeing the designation, development and operation of MACH Translational Platforms
  • Providing advice and strategic direction (as required) to the MACH Board
  • Co-ordinating advocacy for and in response to major funding opportunities across MACH and precinct partners
  • Identifying potential partners for industry engagement



Name: Affiliations: Bio:
Professor Arthur Christopoulos Monash University
Professor Alan Cowman WEHI
Professor Marco Herold Olivia Newton-John Cancer Research Institute
Professor Ricky Johnstone Peter MacCallum Cancer Centre
Professor Tom Kay St Vincent’s Institute
Mr Robert Klupacs Bionics Institute
Professor Sharon Lewin AO Peter Doherty Institute for Infection and Immunity
Professor Keith Martin Centre for Eye Research Australia
Dr Andrew Nash CSL Ltd
Professor Kathryn North AC Murdoch Children's Research Institute
Professor Trevor Kilpatrick The Florey Institute
Professor Sir John Savill Melbourne Academic Centre for Health
Professor Alicia Spittle The University of Melbourne